The Brazil osteoarthritis therapeutics market was valued at USD 305.74 Million in 2024, driven by the rising prevalence of osteoarthritis and obesity across the region. The market is anticipated to grow at a CAGR of 4.20% during the forecast period of 2025-2034, with the values likely to reach USD 461.35 Million by 2034. The market is driven by the growing aging population and increasing awareness about joint health. Advancements in biologics, regenerative therapies, and digital health solutions are expected to accelerate market growth during the forecast period.
Base Year
Historical Period
Forecast Period
The Brazil osteoarthritis therapeutics market is primarily driven by the increasing aging population and the rising prevalence of obesity. These factors contribute to higher demand for effective osteoarthritis treatments and therapeutics.
Key trends shaping the market include the growing shift toward personalized treatments and the integration of advanced technologies like biologics and stem cell therapies in osteoarthritis management, enhancing patient outcomes.
The market is experiencing strong growth due to rising healthcare access, increased patient awareness, and improved therapeutic options. This growth is expected to continue, driven by advancements in treatment technologies.
Value in USD Million
2025-2034
Brazil Osteoarthritis Therapeutics Market Outlook
*this image is indicative*
Osteoarthritis therapeutics focus on alleviating pain, enhancing joint mobility, and slowing the progression of the disease. Treatment options include non-pharmacological methods, over-the-counter pain relievers, prescription medications, disease-modifying agents, and surgical interventions. In Brazil, the market was valued at USD 305.74 Million in 2024. The market is expanding due to the growing elderly population, improved healthcare access, and the increased adoption of advanced treatments such as biologics and minimally invasive surgical procedures, all contributing to enhanced patient outcomes and quality of life.
Rising Prevalence of Obesity to Accelerate the Market Growth
The rising prevalence of obesity in Brazil significantly contributes to the growing demand for osteoarthritis therapeutics. According to a study by Cecilia Alcantara Braga Garcia et al. 2024, obesity affects 20% of Brazilian adults, with higher rates in urban areas such as the capitals, where it reaches 17%. Obesity is a well-known risk factor for osteoarthritis, particularly in the knees and hips, which can accelerate the onset of symptoms and worsen the condition. As a result, the increasing obesity rates in Brazil are expected to fuel the demand for effective osteoarthritis treatments, thereby driving substantial growth in the market.
Some of the key trends in the market are the increasing adoption of advanced, single-injection therapies, driven by strategic international partnerships and rising preference for topical osteoarthritis treatments.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Drug Class
Market Breakup by Dosage Form
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Distribution Channel
Tablets and Capsules are Likely to Experience Significant Market Demand for Segmentation by Dosage Form
Among the common dosage forms used in osteoarthritis therapeutics, tablets and capsules are expected to lead the market, owing to their ease of use, affordability, and convenience in daily administration make them the preferred choice among patients and healthcare providers. Other dosage forms like injections, creams and gels, and others, also contribute to the market value significantly.
Knee Osteoarthritis to Lead the Segmentation by Type
Based on the market segmentation by type, the market is divided into hip osteoarthritis, spinal osteoarthritis, knee osteoarthritis, hand osteoarthritis, and others. Among these, knee osteoarthritis is anticipated to lead the market due to its higher prevalence in the aging population and significant impact on mobility, requiring ongoing therapeutic interventions.
The key features of the market report comprise clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in São Paulo, Brazil, and established in 2001, Hypera Pharma is a leading pharmaceutical company active in the market. The company launched Ecoxe, an etoricoxib-based prescription medication used for managing pain and inflammation associated with osteoarthritis and rheumatoid arthritis. This reinforces Hypera Pharma’s strategic focus on expanding its therapeutic portfolio and strengthening its presence in the pain management segment.
Bioventus Inc., established in 2012 and headquartered in Durham, North Carolina, is a global provider of orthobiologic solutions focused on healing and pain management. In Brazil, the company contributes to osteoarthritis care through Durolane, a single-injection hyaluronic acid therapy approved by ANVISA for knee and hip osteoarthritis. Distributed exclusively by Pfizer, Durolane supports Bioventus' strategy to offer advanced joint preservation treatments in osteoarthritis markets.
Headquartered in Pittsburgh, Pennsylvania, and established in 1961, Mylan N.V. is a global pharmaceutical leader recognized for its high-quality generic and specialty medicines. Within Brazil’s osteoarthritis therapeutics market, Mylan plays a vital role through its Nabumetone Tablets, approved by the U.S. FDA and therapeutically equivalent to reference treatments for osteoarthritis and rheumatoid arthritis. The company’s extensive product pipeline and international reach strengthen its presence and contribution to accessible arthritis care in Brazil.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies in the market include Pfizer inc., and Novartis AG.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Drug Class |
|
| Breakup by Dosage Form |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share